Ambulatory Transition from Parenteral Prostanoid to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension

被引：0
|
作者：
Lucas M. Kimmig
Chuanhong Liao
Remzi Bag
机构：
[1] The University of Chicago Medicine,Section of Pulmonary and Critical Care Medicine
[2] The University of Chicago,Department of Public Health Sciences
[3] The University of Chicago,Biological Sciences Division
来源：
Lung | 2020年 / 198卷
关键词：
Pulmonary arterial hypertension; Prostacyclins; Prostanoids; Inhaled prostanoids; Transition;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：53 / 58
页数：5
相关论文
共 50 条
  • [1] Ambulatory Transition from Parenteral Prostanoid to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension
    Kimmig, Lucas M.
    Liao, Chuanhong
    Bag, Remzi
    LUNG, 2020, 198 (01) : 53 - 58
  • [2] Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertension
    Raina, Amresh
    Coons, James C.
    Kanwar, Manreet
    Murali, Srinivas
    Sokos, George
    Benza, Raymond L.
    PULMONARY CIRCULATION, 2013, 3 (01) : 116 - 120
  • [3] Safety and efficacy of transition from inhaled treprostinil to parenteral treprostinil in selected patients with pulmonary arterial hypertension
    Preston, Ioana R.
    Feldman, Jeremy
    White, James
    Franco, Veronica
    Ishizawar, David
    Burger, Charles
    Waxman, Aaron B.
    Hill, Nicholas S.
    PULMONARY CIRCULATION, 2014, 4 (03) : 456 - 461
  • [4] Safety And Tolerability Of Outpatient Transition Of Parenteral And Inhaled Treprostinil To Oral Treprostinil In Patients With Pulmonary Arterial Hypertension
    Khan, A. A.
    Ackerbauer, K.
    Tandon, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [5] Successful transition from parenteral to inhaled prostanoid therapy in pulmonary arterial hypertension
    Smith, Kelly J.
    Mallory, George B.
    CHEST, 2006, 130 (04) : 239S - 239S
  • [6] Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension
    Bourge, Robert C.
    Tapson, Victor F.
    Safdar, Zeenat
    Benza, Raymond L.
    Channick, Richard N.
    Rosenzweig, Erika B.
    Shapiro, Shelley
    White, Richard James
    McSwain, Christopher Shane
    Gotzkowsky, Stephen Karl
    Nelsen, Andrew C.
    Rubin, Lewis J.
    CARDIOVASCULAR THERAPEUTICS, 2013, 31 (01) : 38 - 44
  • [7] Transition From Inhaled Treprostinil to Selexipag in Pulmonary Arterial Hypertension
    El-Kersh, Karim
    Smith, J. Shaun
    AMERICAN JOURNAL OF THERAPEUTICS, 2017, 24 (05) : E620 - E621
  • [8] Transition from parenteral to oral treprostinil in pulmonary arterial hypertension
    Chakinala, Murali M.
    Feldman, Jeremy P.
    Rischard, Franz
    Mathier, Michael
    Broderick, Meredith
    Leedom, Nicole
    Laliberte, Kevin
    White, R. James
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (02): : 193 - 201
  • [9] Transition to Oral Treprostinil from Parenteral or Inhaled Treprostinil or as Add-On Therapy in Pediatric Subjects with Pulmonary Arterial Hypertension
    Ivy, D.
    Feinstein, J.
    Yung, D.
    Mullen, M.
    Kirkpatrick, E.
    Hirsch, R.
    Austin, E. D.
    Fineman, J.
    Doran, A.
    Solum, D.
    Deng, C.
    Hopper, R. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [10] Parenteral and Inhaled Prostanoid Therapy in the Treatment of Pulmonary Arterial Hypertension
    McLaughlin, Vallerie V.
    Palevsky, Harold I.
    CLINICS IN CHEST MEDICINE, 2013, 34 (04) : 825 - +
12345